Stephen Mandel
Lone Pine Capital
Stephen Mandel HCA Healthcare, Inc stake
total: 304
Lone Pine Capital HCA trades
- Total transactions:
- 5
- New positions:
- 2
- Sold out:
- 2
- Reduced:
- 1
- Held since:
- 2016 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q4
According to 2026 Q2 report, Stephen Mandel doesn't hold any HCA Healthcare, Inc (HCA) shares. To date, the estimated cost basis is nearly $75.63 for "buy" trades and estimated average "sell" price is $75.63. Lone Pine Capital first purchased HCA in 2014 Q4, initially acquiring about 5.84M shares. Stephen Mandel later completely sold out the position and invested in HCA Healthcare, Inc again in 2016 Q3. Since the initial investment in HCA Healthcare, Inc (HCA), Lone Pine Capital has made 4 more transactions.
When did Stephen Mandel sell HCA Healthcare, Inc (HCA)?
Stephen Mandel sold off the entire HCA Healthcare, Inc (HCA) position in 2016 Q4.
When did Stephen Mandel buy HCA Healthcare, Inc (HCA)?
Stephen Mandel first invested in HCA Healthcare, Inc (HCA) in 2014 Q4 at the reported quarter-end price of $73.39 per share.
What's the cost basis of Lone Pine Capital's HCA stake?
The estimated cost basis for HCA Healthcare, Inc (HCA) stake is around $75.63 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $75.63
- Weighted AVG sell price:
- $75.63
Stephen Mandel's historical trades in HCA Healthcare, Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q4
|
0.00%
|
$75.63
|
-100% (-1,669,543)
|
|||
|
2016 Q3
|
0.56%
|
$75.63
|
new
|
|||
|
2015 Q3
|
0.00%
|
$90.72
|
-100% (-5,007,242)
|
|||
|
2015 Q2
|
2.02%
|
$90.72
|
-14.21% (-829,630)
|
|||
|
2014 Q4
|
1.83%
|
$73.39
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.